polyethylene glycol 3350 / potassium chloride / sodium bicarbonate / sodium chloride Powder for Oral Solution
RxNorm concept 1718982, clinical dose form (scdf).
- RxCUI
- 1718982
- Term type
- Clinical dose form (SCDF)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1718982 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- Powder for Oral Solution (DF, has dose form)
- potassium chloride (IN, has ingredient)
- sodium chloride (IN, has ingredient)
- sodium bicarbonate (IN, has ingredient)
- polyethylene glycol 3350 (IN, has ingredient)
- polyethylene glycol 3350 / potassium chloride / sodium bicarbonate / sodium chloride Powder for Oral Solution [Gavilyte-H] (SBDF, has tradename)
- polyethylene glycol 3350 / potassium chloride / sodium bicarbonate / sodium chloride Powder for Oral Solution [GaviLyte-N] (SBDF, has tradename)
- polyethylene glycol 3350 / potassium chloride / sodium bicarbonate / sodium chloride Powder for Oral Solution [TriLyte] (SBDF, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1718982 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1718982 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1718982. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.